à Please note: The agenda is a work in progress and will evolve as new speakers are confirmed. Please check back regularly for updates ahead of the event.
Opening Activities
08:00 Registration Opens | Partnering Sessions, and Networking in the Exhibition Area
08:40 Welcome | Opening Remarks
Moderator: Nina Rawal, Venture Capital Investor & Board Member
Session 1 | The European & Nordic Life Science Landscape
08:45 Global Shifts, Local Consequences – Implications for Swedish & Danish Life Science
Pieter van der Meijden, Managing Director Healthcare Investment Banking, DNB Carnegie Back Bay
09:05 European Life Science in Transition – A Decisive Moment to Tackle Global Challenges
Sofia Wallström, Board member, EFPIA – European Federation of Pharmaceutical Industries and Associations
09:20 MedTech and EU Regulations – Past, Present, and Beyond
Åsa Betten, CEO, RISE Medical Notified Body
09:40 TBA | (National Industry Perspective: Denmark)
Katrina Feilberg, Industry Director, Health & Life Science, Danish Chamber of Commerce
09:55 Sweden Incorporated: Innovation, Resilience, and the Road Ahead
Jessica Martinsson, CEO, SwedenBIO
10:10 European Competitiveness Through Strategic Multiplication
Stefan Jovinge, President of Research, Education, Development and Innovation, Scania University Hospital
10:25 TBA | Interview or Panel Discussion: Barriers to Collaboration – What’s Holding Us Back?
10:40 Coffee, Partnering Sessions, and Networking in the Exhibition Area
11:00 Quantum Life Sciences and Applications
Ebba Carbonnier, CEO, QuNorth
Session 2 | Talent & Workforce – Building the Future Life Science Ecosystem
11:20 Where Science Meets Digital: Building the Next Generation Workforce in Danish and Swedish Life Sciences
Niels Buch Leander, Executive Vice President, Chief Digital Officer, PharmaRelations
11:40 Academic-Industry Collaboration for Skills Development
Andreas Inghammar, Deputy Dean, Lund University School of Economics and Management
12:00 TBA | Attracting and Retaining Talent in a Competitive Global Market
12:20 Lunch, Partnering Sessions, and Networking in the Exhibition Area
Session 3 | Innovation & Commercialization – From Research to Market
13:00 BII’s Perspective on Bringing Science to Life
Trine Bartholdy, Chief Business Officer, BioInnovation Institute
13:15 From Innovation to International Impact
Fredrik Olsson, CEO, Genovis
13:25 TBA | Startup / Scale-up Case
Cristiana Pires, CEO & Co-founder, Asgard Therapeutics
13:35 Insurance in Life Science: From Risk to Resilience
Johan Berg, Head of Large & Complex, Gallagher
Isak Öjelid, Senior Insurance Broker, Gallagher
13:50 Bridging Discovery and Clinical Impact: The Role of CRO Expertise in Modern Drug Development
Karin Enell Smith, PhD, Head of CRO Services, Svar Life Science
14:05 Better Samples – Better Science: Introducing a Novel Cryo Storage Technology for Biobanks
Hans-Christoph Paul, Owner, HCP Life Science Innovation
Gesine Paul-Visse, Conslutant Neurologist, Professor, Lund University & Skåne University Hospital
14:20 Coffee, Partnering Sessions, and Networking in the Exhibition Area
Session 4 | Funding & Investment – Financing the Nordic Life Science Growth
14:50 Building Biotech Companies in the Nordics
Søren Møller, Managing Partner, Seed Investments, Novo Holdings
15:10 TBA
15:30 TBA
15:50 Panel Discussion: Building World-Class Companies That Attract Global Investors
Markus Neuding, Owner, Sedermera Corporate Finance
Emanuel Stihl, Managing Partner FSG Fund I, Fåhraeus Startup And Growth
Session 5 | Concluding Activities
16:05 Looking Ahead: Cross-Border Collaboration & Next Steps
Short, interactive discussion, summarizing key takeaways.
16:15 Science After Work – Networking Reception in the Exhibition Area
A great opportunity to unwind and continue the discussions in a relaxed setting, while enjoying drinks & refreshments.